It's an entirely different day for patient advocacy, yet we've only scratched the surface of what's possible. Marc Iskowitz talks to advocates and their pharma counterparts, and some of the newer players, about what's standing in the way of deeper collaboration
from Most popular articles from Medical Marketing and Media http://ift.tt/1GAshGb
No comments:
Post a Comment